DermTech Other Current Liab from 2010 to 2024
| DMTK Stock | USD 0.35 0.04 10.26% |
Other Current Liabilities | First Reported 2014-03-31 | Previous Quarter 8.7 M | Current Value 7.2 M | Quarterly Volatility 4.3 M |
Check DermTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DermTech main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 1.6 M or Selling General Administrative of 46 M, as well as many exotic indicators such as Price To Sales Ratio of 3.55, Dividend Yield of 0.0 or PTB Ratio of 0.95. DermTech financial statements analysis is a perfect complement when working with DermTech Valuation or Volatility modules.
DermTech | Other Current Liab |
Latest DermTech's Other Current Liab Growth Pattern
Below is the plot of the Other Current Liab of DermTech over the last few years. It is DermTech's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DermTech's overall financial position and show how it may be relating to other accounts over time.
| Other Current Liab | 10 Years Trend |
|
Other Current Liab |
| Timeline |
DermTech Other Current Liab Regression Statistics
| Arithmetic Mean | 2,771,443 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 145.63 | |
| Mean Deviation | 3,264,245 | |
| Median | 125,918 | |
| Standard Deviation | 4,036,009 | |
| Sample Variance | 16.3T | |
| Range | 11.4M | |
| R-Value | 0.84 | |
| Mean Square Error | 5.3T | |
| R-Squared | 0.70 | |
| Significance | 0.0001 | |
| Slope | 753,920 | |
| Total Sum of Squares | 228.1T |
DermTech Other Current Liab History
About DermTech Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include DermTech income statement, its balance sheet, and the statement of cash flows. DermTech investors use historical funamental indicators, such as DermTech's Other Current Liab, to determine how well the company is positioned to perform in the future. Although DermTech investors may use each financial statement separately, they are all related. The changes in DermTech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on DermTech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on DermTech Financial Statements. Understanding these patterns can help to make the right decision on long term investment in DermTech. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Current Liabilities | 8.7 M | 9.1 M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as DermTech using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of DermTech Correlation against competitors. For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for DermTech Stock analysis
When running DermTech's price analysis, check to measure DermTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DermTech is operating at the current time. Most of DermTech's value examination focuses on studying past and present price action to predict the probability of DermTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DermTech's price. Additionally, you may evaluate how the addition of DermTech to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is DermTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DermTech. If investors know DermTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DermTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.65) | Revenue Per Share 0.465 | Quarterly Revenue Growth 0.106 | Return On Assets (0.39) | Return On Equity (1.22) |
The market value of DermTech is measured differently than its book value, which is the value of DermTech that is recorded on the company's balance sheet. Investors also form their own opinion of DermTech's value that differs from its market value or its book value, called intrinsic value, which is DermTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DermTech's market value can be influenced by many factors that don't directly affect DermTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DermTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if DermTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DermTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.